Faculty | Professors

Bjorn Erik Oskarsson, M.D.
Assistant Professor of Clinical Neurology
Director of the Multidisciplinary ALS clinic
Specialty: Neurology
Lawrence J. Ellison Ambulatory Care Center
4860 Y St., Suite 0100
Sacramento, CA 95817
(916) 734-3588
UC Davis Medical Center
2315 Stockton Blvd., Suite 5308
Sacramento, CA 95817
Clinical & Research Interests
Dr. Björn Oskarsson's objectives are to help people with neuromuscular diseases by finding the correct diagnosis, utilizing the best medications and other interventions available today, and developing better treatment for the future.
Dr. Oskarsson directs the UCDavis ALS clinic, a multidisciplinary clinic that provides comprehensive ALS care according to national guidelines. Dr. Oskarsson collaborates with therapists and other specialists, and connects patients with resources in the community.
Dr. Oskarsson is Board certified in Electrodiagnostic Medicine and performs EMG/NCS. Dr. Oskarsson is Board certified in Neuromuscular Medicine and performs and interprets muscle and nerve biopsies.
Dr. Oskarsson’s research interests include studies developing better treatments of ALS and studies aimed at gaining a better understanding of why ALS occurs. Dr. Oskarsson works with the UCD Center for Regenerative Cures to develop stem cell treatments for ALS.
Other Languages
Swedish
Education
Lund University Faculty of Medicine
Lund
Sweden
M.D. 1999
Gothenburg University Faculty of Medicine
Gothenburg
Sweden
Pre-Med 1996
Internships
University of Colorado
Denver, Colorado
2001
Medicine
Residency
University of Colorado
Denver, Colorado
2004
Neurology
Fellowships
University of Colorado
Denver, Colorado
2005
Electrodiagnostic Medicine
University of Colorado
Denver, Colorado
2006
Neuromuscular Medicine
Professional Memberships
ALS Research Group - Board member
American Academy of Neurology
American Association of Neuromuscular & Electrodiagnostic
North Eastern ALS (NEALS) study group
Western ALS (WALS) study group
World Federation of Neurology Research group on Motor Neuron Diseases
Select Recent Publications
Gordon, P.H., Moore, D.H., Miller, R.G., Florence, J.M., Verheijde, J.L., Doorish, C., Hilton, J.F., Spitalny, G.M., Macarthur, R.B., Mitsumoto, H., Neville, H.E., Boylan, K., Mozaffar, T., Belsh, J.M., Ravits, J., Bedlack, R.S., Graves, M.C., McCluskey, L.F., Barohn, R.J., Tandan, R.; for the Western ALS Study Group (Oskarsson, B. as a member of the Western ALS group) (2007). Efficacy of minocycline in patients with amyotrophic lateral sclerosis: A phase III randomised trial. Lancet Neurology, 6(12), 1045-1053.
Oskarsson, B., Pelak, V.S., Quan, D., Hall, D., Foster, C., Galetta, S. (2008). Stiff eyes in stiff person syndrome. Neurology, 71(5), 378-379.
Buchsbaum, R., Kaufmann, P., Barsdorf, A.I., Arbing, R., Montes, J., Thompson, J.L., for The QALS Study Group (Oskarsson, B. as a member of the QALS group) (2009). Web-based data management for a phase II clinical trial in ALS. Amyotrophic Lateral Sclerosis, 10(5-6), 374-7.
Oskarsson, B., Zawadzki, L., Benke, T., Quan, D. (2009). Neuromuscular hyperexcitability associated with acetylcholine receptor antibodies in a child. Journal of Child Neurology, 24(1), 90-2.
Kaufmann, P., Thompson, J.L., Levy, G., Buchsbaum, R., Shefner, J., Krivickas, L.S., Katz, J., Rollins, Y., Barohn, R.J., Jackson, C.E., Tiryaki, E., Lomen-Hoerth, C., Armon, C., Tandan, R., Rudnicki, S.A., Rezania, K., Sufit, R., Pestronk, A., Novella, S.P., Heiman-Patterson, T., Kasarskis, E.J., Pioro, E.P., Montes, J., Arbing, R., Vecchio, D., Barsdorf, A., Mitsumoto, H., Levin, B.; QALS Study Group. (Oskarsson, B. as a member of the QALS group) (2009). Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology, 66(2), 235-44.
Oskarsson, B., Quan, D., Rollins, Y.D., Neville, H., Ringel, S.P., Arciniegas, D.B. (2010). Using the frontal assessment battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotrophic Lateral Sclerosis, 11(1-2), 244-7.
Pioro, E.P., Brooks, B.R., Cummings, J., Schiffer, R., Thisted, R.A., Wynn, D., Hepner, A., Kaye, R. (2010). Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators. (Oskarsson B as a member of the PBA Investigators). (2010) Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. Nov;68(5):693-702.
Oskarsson, B. (2011). Myopathy: Five new things. Neurology (Clinical Practice Suppl 2), 76(7),S14-19.
Deane, K.D., Tyler, K.N., Johnson, D.W., Tanabe, J.L., Oskarsson, B., Nitka, E., Brass, E., Davies, J.K., Striebich, C.C. (2011). Susac's syndrome and pregnancy: A case report and discussion of disease management. Journal of Clinical Rheumatology. Mar;17(2):83-8.

